204 related articles for article (PubMed ID: 23843560)
1. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
2. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
3. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
4. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Porto AF; Neva FA; Bittencourt H; Lisboa W; Thompson R; Alcântara L; Carvalho EM
Parasite Immunol; 2001 Sep; 23(9):503-7. PubMed ID: 11589779
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia.
Ratner L; Grant C; Zimmerman B; Fritz J; Weil G; Denes A; Suresh R; Campbell N; Jacobson S; Lairmore M
Am J Hematol; 2007 Oct; 82(10):929-31. PubMed ID: 17617788
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
9. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
10. Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth.
Springer LE; Patton JB; Zhan T; Rabson AB; Lin HC; Manser T; Lok JB; Hess JA; Abraham D
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009559. PubMed ID: 34314415
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
[TBL] [Abstract][Full Text] [Related]
12. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
13. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
14. Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).
Agapé P; Copin MC; Cavrois M; Panelatti G; Plumelle Y; Ossondo-Landeau M; Quist D; Grossat N; Gosselin B; Fenaux P; Wattel E
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(4):394-402. PubMed ID: 10096585
[TBL] [Abstract][Full Text] [Related]
15. Utility of PCR in Patients with
Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M
Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152
[No Abstract] [Full Text] [Related]
16. [Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection].
Guevara Miranda J; Guzmán Rojas P; Espinoza-Ríos J; Mejía Cordero F
Rev Gastroenterol Peru; 2017; 37(2):169-172. PubMed ID: 28731999
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.
Stewart DM; Ramanathan R; Mahanty S; Fedorko DP; Janik JE; Morris JC
Acta Haematol; 2011; 126(2):63-7. PubMed ID: 21474923
[TBL] [Abstract][Full Text] [Related]
18. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
Gillet NA; Cook L; Laydon DJ; Hlela C; Verdonck K; Alvarez C; Gotuzzo E; Clark D; Farré L; Bittencourt A; Asquith B; Taylor GP; Bangham CR
PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987
[TBL] [Abstract][Full Text] [Related]
19. Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan.
Tanaka T; Hirata T; Parrott G; Higashiarakawa M; Kinjo T; Kinjo T; Hokama A; Fujita J
Am J Trop Med Hyg; 2016 Feb; 94(2):365-370. PubMed ID: 26621566
[TBL] [Abstract][Full Text] [Related]
20. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]